From: Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori
Baseline HP status and treatment | HP status after 12Â months | Total | |
---|---|---|---|
Negative n = 536 | Positive n = 107 | ||
HP-/AZ | 269 (97.1%) | 8 (2.9%) | 277 (100%) |
HP-/PL | 240 (94.9%) | 13 (5.1%) | 253 (100%) |
Total (HP-) | 509 (96.0%) | 21 (4.0%) | 530 (100%) |
HP+/AZ | 11 (20.4%) | 43 (79.6%) | 54 (100%) |
HP+/PL | 16 (27.1%) | 43 (72.9%) | 59 (100%) |
Total (HP+) | 27 (23.8%) | 86 (76.2%) | 113 (100%) |